Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for SHPMF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SHPMF and 80,000+ other tickers.
See exactly how SHPMF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SHPMF and 80,000+ other tickers.
Shanghai Pharmaceuticals Holding Co., Ltd. functions as an investment holding company deeply involved in various facets of China's pharmaceutical and healthcare sectors. Its primary activities include the research, development, production, distribution, and retail of a diverse array of medical and health-related products. The company organizes its operations across four segments: Production, Distribution, Retail, and Others. Its extensive product portfolio encompasses chemical and biochemical medications, traditional Chinese medicines, health products, and medical devices. These target a…
